Search

EHA-ECL led statement calls for protection of the Hospital Exemption

The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.

Read more

Multi-center acute myeloid leukemia study

An SWG Grant-supported project initiated by EHA's SWG on Acute Myeloid Leukemia.

Read more

Standards for functional precision medicine project

An SWG Grant-supported project initiated by EHA's SWG on Precision Hematology.

Read more

Splenic marginal zone lymphoma study

An SWG Grant-supported project initiated by the EHA Lymphona Group.

Read more

CAR NK-cells project

An SWG Grant-supported project initiated by EHA's SWG on Immune Therapies for Hematologic Disorders.

Read more

Long-lasting, late-onset, and chronic idiopathic neutropenia project

An SWG Grant-supported project initiated by EHA's SWG on Granulocytes and Constitutional Marrow Failure Disorders.

Read more

European registry on inherited platelet disorders project

An SWG Grant-supported project initiated by EHA's SWG on Thrombocytopenia and Platelet Function Disorders.

Read more

SWG Grant-funded projects, 2024

In November and December of 2023, SWGs were invited to develop project ideas and apply for a 2024 SWG Grant. ApplicationsWe received 11 different applications from 9 SWGs. This was two more applications than we received in 2022.

Read more

SWG Grant-funded projects, 2023

In November and December of 2022, SWGs were invited to develop project ideas and apply for a 2023 SWG Grant. ApplicationsWe received nine different applications from six SWGs.

Read more

Splenic marginal zone lymphoma study update, February 2024

A project update from Dr Ahmed Ludvigsen Al-Mashhadi. I am truly grateful for this opportunity provided by EHA, and for EHA's effort in advancing research in a field that may otherwise be very difficult to explore.

Read more